Vident Advisory’s Nuvalent NUVL Stock Holding History

Vident Advisory’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$402K	Sell	3,257 -9	-0.3%	-$968	﹤0.01%	1476
2026 Q1	$335K	Buy	+3,266	New	+$333K	﹤0.01%	1450

Other funds holding NUVL

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Vident Advisory's NUVL Position: Q2 2026 in Review

Vident Advisory reduced its Nuvalent (NUVL) stake by 0.28% in Q2 2026, selling an estimated $968 and leaving 3,257 shares worth $402K. The position accounts for ﹤0.01% of the portfolio, ranked #1476.

Vident Advisory first reported a position in NUVL in Q1 2026 and has held it in 2 quarters since. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

Vident Advisory held 3,257 shares of Nuvalent worth $402K as of Q2 2026.
Vident Advisory sold 9 Nuvalent shares in Q2 2026, an estimated $968.
Nuvalent made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1476 holding.
Vident Advisory first reported a position in Nuvalent in Q1 2026 and has held it in 2 quarters since.
293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.